Navigation Links
Musculoskeletal Network Features New Research into the Cause of Rheumatoid Arthritis and Lupus

NORWALK, Conn., March 25, 2013 /PRNewswire/ -- UBM Medica US announces that Musculoskeletal Network highlights growing evidence supporting the idea that many conditions related to arthritis are caused by cross-reactions between immune responses against infections and damage to the body's own tissues.

Diseases such as rheumatoid arthritis and lupus may be an indication of a defect in the body's ability to fight infection, rather than an over-reaction to it, writes rheumatologist Stephen Paget MD, physician-in-chief emeritus at the Hospital for Special Surgery in New York. Forthcoming research may confirm that, for many people with unexplainable conditions that cause joint pain and swelling, the unrecognized cause is infection, he predicts, pointing to a new focus for prevention and treatment.

Among the evidence behind his startling hypothesis, Dr. Paget points out that:

  • Rheumatoid arthritis has been strongly linked to periodontal disease, bacterial infection of the gums.
  • Some patients affected with Lyme disease, which is caused by a tick-borne bacterium, continue to have joint problems after all evidence of a living bacterium disappears.
  • The bacterium Chlamydia trachomatis, cause of a sexually transmitted disease (STD) that is often asymptomatic, can persist for years within joints, causing inflammation.

New research into the genomes of microorganisms, sponsored by a major government initiative, is revealing many infectious agents that were previously unknown, Dr. Paget points out, and more remain to be discovered.

About UBM Medica US

Addressing today's healthcare information needs, UBM Medica US delivers strategic, integrated communications solutions and comprehensive reach—online, in print, and via custom programs. Improving the effectiveness of healthcare through information and education, UBM Medica US provides unbiased clinical, practical, and business information for physicians, providers, payers, and patients around the world. Through journals, magazines, websites, online communities, drug databases, digital events, and other valuable resources, UBM Medica US also delivers comprehensive communication solutions for the pharmaceutical and related industries. Websites include,,,,,, and UBM Medica US is part of UBM Connect—which provides marketing services across a number of communities, the largest of which are healthcare, medical device design and advanced manufacturing. UBM Connect also includes UBM Studios, the global leader in interactive digital environments. UBM Connect is a UBM plc company. For more information, visit

Media contact:

Jason J. Golden
Content Marketing Manager

Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. MiMedx to Present at the Canaccord Genuity Musculoskeletal Conference
2. Musculoskeletal Network Features Update on Nutraceuticals for Osteoarthritis
3. GNS Healthcare Joins Orion Bionetworks to Develop Predictive Models for Multiple Sclerosis and Other Diseases
4. VIC Investor Network to Significantly Accelerate Technology Company Growth
5. Researchers create building block of quanutm networks
6. Secretary of Department of Environmental Protection, Michael Krancer, to Facilitate Networking Session at Pittcon 2013
7. MDA Launches Clinical Network to Speed Myotonic Dystrophy Research
8. Notre Dame to be part of $194 million university research center network
9. House to Vote on Post-Sandy Mold Relief Fund Next Week; Dr Mold Network Comments Amount is Truly Needed by Hurricane Victims
10. Mold Linked With Fatal Asthma and Allergy Attacks; Dr Mold Network Suggests Use of Molderizer and Safe Shield for Safer Mold Treatment
11. Possible Mold Infestation at Queens School Worries Parents; Doctor Mold Network Suggests a Mold Spray for a Safe and Effective Mold Remediation Process
Post Your Comments:
(Date:6/27/2016)... , ... June 27, 2016 , ... ... bring innovative medical technologies, services and solutions to the healthcare market. The company's ... of various distribution, manufacturing, sales and marketing strategies that are necessary to help ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... -- The Prostate Cancer Foundation (PCF) is pleased to announce 24 new ... prostate cancer. Members of the Class of 2016 were selected from a pool ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology:
(Date:6/2/2016)... June 2, 2016   The Weather Company , an ... Ads, an industry-first capability in which consumers will be able ... to ask questions via voice or text and receive relevant ... Marketers have long sought an advertising solution ... can be personal, relevant and valuable; and can scale across ...
(Date:5/24/2016)... 2016 Ampronix facilitates superior patient care by providing unparalleled technology to leaders ... is the latest premium product recently added to the range of products distributed by ... ... ... LCD Medical Display- Ampronix News ...
(Date:5/12/2016)... , May 12, 2016 ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
Breaking Biology News(10 mins):